Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-24
DOI
10.3389/fendo.2021.637209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial
- (2020) Gudmundur Johannsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Similar safety and efficacy in previously treated adults with growth hormone deficiency randomised to once‐weekly somapacitan or daily growth hormone
- (2020) Fumio Otsuka et al. CLINICAL ENDOCRINOLOGY
- Individual sensitivity to growth hormone replacement in adults
- (2020) Cesar Luiz Boguszewski REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study
- (2019) Young-Jun Rhie et al. PLoS One
- Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective
- (2019) Paulo F. Collett-Solberg et al. Hormone Research in Paediatrics
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE
- (2019) Kevin C. J. Yuen et al. Endocrine Practice
- Long-Acting Growth Hormone Preparations – Current Status and Future Considerations
- (2019) Bradley S Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials
- (2018) Rasmus Vestergaard Juul et al. CLINICAL PHARMACOKINETICS
- Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial
- (2018) Gudmundur Johannsson et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults
- (2018) Cheol Ryong Ku et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A first-in-man phase 1 trial for long-acting TransCon Growth Hormone
- (2018) David Gilfoyle et al. GROWTH HORMONE & IGF RESEARCH
- Once-Weekly Administration of Sustained-Release Growth Hormone in Korean Prepubertal Children with Idiopathic Short Stature: A Randomized, Controlled Phase II Study
- (2018) Jin Soon Hwang et al. Hormone Research in Paediatrics
- Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies
- (2017) Xiaoping Luo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone
- (2017) Peter Thygesen et al. GROWTH HORMONE & IGF RESEARCH
- Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children
- (2017) Dennis M. Fisher et al. Hormone Research in Paediatrics
- A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency
- (2017) Pierre Chatelain et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Acting C-Terminal Peptide–Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children
- (2017) Nataliya Zelinska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency
- (2017) Charlotte Höybye et al. Endocrine Connections
- The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
- (2017) Kennett Sprogøe et al. Endocrine Connections
- Treatment of growth hormone deficiency in children, adolescents and at the transitional age
- (2016) Erick Richmond et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations: Table 1
- (2016) Jens Sandahl Christiansen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults
- (2016) Christian J Strasburger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Early cessation and non-response are important and possibly related problems in growth hormone therapy: An OZGROW analysis
- (2016) Ian P. Hughes et al. GROWTH HORMONE & IGF RESEARCH
- 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), Paris, France, September 10-12, 2016: Abstracts
- (2016) Hormone Research in Paediatrics
- Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency
- (2016) Adda Grimberg et al. Hormone Research in Paediatrics
- Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency
- (2016) Michael Højby Rasmussen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency
- (2016) Wayne V. Moore et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Three-year experience with access to nationally funded growth hormone (GH) replacement for GH-deficient adults
- (2015) I.M. Holdaway et al. CLINICAL ENDOCRINOLOGY
- GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
- (2015) D B Allen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency
- (2015) Orit Cohen-Barak et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Status of long-acting-growth hormone preparations — 2015
- (2015) Charlotte Høybye et al. GROWTH HORMONE & IGF RESEARCH
- Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
- (2015) Luo et al. Drug Design Development and Therapy
- A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile
- (2014) Michael Højby Rasmussen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults
- (2013) Kevin C. J. Yuen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Controlled release of human growth hormone fused with a human hybrid Fc fragment through a nanoporous polymer membrane
- (2013) Eung-Sam Kim et al. Nanoscale
- Long-Acting Growth Hormone
- (2013) Charlotte Höybye et al. PEDIATRIC DRUGS
- 12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency
- (2012) Beverly M. K. Biller et al. Pituitary
- Administration Burden Associated With Recombinant Human Growth Hormone Treatment: Perspectives of Patients and Caregivers
- (2012) Dianne Kremidas et al. Journal of Pediatric Nursing-Nursing Care of Children & Families
- Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics
- (2011) Jean de Schepper et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
- (2011) Mark E. Molitch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Acting Growth Hormone for Replacement Therapy
- (2011) Gudmundur Johannsson JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Three-Year Efficacy and Safety of LB03002, a Once-Weekly Sustained-Release Growth Hormone (GH) Preparation, in Prepubertal Children with GH Deficiency (GHD)
- (2011) Ferenc Péter et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH
- (2009) Philippe Touraine et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started